03/22/2024 10:26 AM | Belite Bio (Subject) Chen Wan-Shan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024 7:00 AM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 2:58 PM | Belite Bio (Subject) MATA NATHAN L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 7:51 PM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 8:05 PM | Belite Bio (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/11/2024 8:59 PM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024 8:08 PM | Belite Bio (Subject) Lin Yu-Hsin (Filed by)
| Form SC 13G | |
02/12/2024 7:40 PM | Belite Bio (Subject) Lin Bioscience International Ltd. (Filed by)
| Form SC 13G | |
12/28/2023 3:15 PM | Belite Bio (Subject) Chuang Hao-Yuan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023 3:16 PM | Belite Bio (Subject) Lin Yu-Hsin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 3:36 PM | Belite Bio (Subject) Lin Yu-Hsin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 3:41 PM | Belite Bio (Subject) Chuang Hao-Yuan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 7:00 AM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023 11:08 AM | Belite Bio (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/31/2023 4:16 PM | Belite Bio (Subject) Lin Yu-Hsin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 5:06 AM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2023 5:07 AM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023 3:32 PM | Belite Bio (Filer)
| Form 424B5 | |
06/16/2023 3:36 PM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023 8:55 PM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023 11:15 PM | Belite Bio (Filer)
| Form EFFECT | |
05/09/2023 11:15 PM | Belite Bio (Filer)
| Form EFFECT | |
05/01/2023 3:34 PM | Belite Bio (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
04/25/2023 3:30 PM | Belite Bio (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |